NO921513L - Komplekser av polyadenylsyre med polyuridylsyre - Google Patents

Komplekser av polyadenylsyre med polyuridylsyre

Info

Publication number
NO921513L
NO921513L NO92921513A NO921513A NO921513L NO 921513 L NO921513 L NO 921513L NO 92921513 A NO92921513 A NO 92921513A NO 921513 A NO921513 A NO 921513A NO 921513 L NO921513 L NO 921513L
Authority
NO
Norway
Prior art keywords
acid
complex
polyuridylic
polyadenylic
poly
Prior art date
Application number
NO92921513A
Other languages
English (en)
Other versions
NO921513D0 (no
Inventor
Ara G Hovanessian
Evelyne Deschamps De Paillette
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of NO921513D0 publication Critical patent/NO921513D0/no
Publication of NO921513L publication Critical patent/NO921513L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen angår et terapeutisk preparat for behandling av AIDS og tilsvarende infeksjoner, og hvor preparatet inneholder fra 0,1 til 100% av komplekset Poly(A).Poly(U) eventuelt sammen med et annet middel mot AIDS og som virker på HIV-viruset etter en annen mekanisme enn den man finner i komplekset Poly(A).Poly(U), og sammen med farmasøytisk akseptable fortynningsmidler eller bærerstoffer.
NO92921513A 1991-04-16 1992-04-15 Komplekser av polyadenylsyre med polyuridylsyre NO921513L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108085A GB9108085D0 (en) 1991-04-16 1991-04-16 Complexes of polyadenylic acid with polyuridylic acid

Publications (2)

Publication Number Publication Date
NO921513D0 NO921513D0 (no) 1992-04-15
NO921513L true NO921513L (no) 1992-10-19

Family

ID=10693367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921513A NO921513L (no) 1991-04-16 1992-04-15 Komplekser av polyadenylsyre med polyuridylsyre

Country Status (19)

Country Link
US (2) US5756477A (no)
EP (1) EP0509906A1 (no)
JP (1) JPH05262653A (no)
KR (1) KR100233393B1 (no)
AU (1) AU656574B2 (no)
BE (1) BE1004857A3 (no)
CA (1) CA2066134C (no)
CH (1) CH684521A5 (no)
DK (1) DK51192A (no)
DZ (1) DZ1570A1 (no)
FR (1) FR2675384B1 (no)
GB (2) GB9108085D0 (no)
IE (1) IE921208A1 (no)
LU (1) LU88102A1 (no)
MY (1) MY108106A (no)
NO (1) NO921513L (no)
OA (1) OA09577A (no)
SE (1) SE509801C2 (no)
ZA (1) ZA922699B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6734192B1 (en) 1999-08-23 2004-05-11 Mp-1 Inc. Treatment of viral infections
US7875283B2 (en) * 2000-04-13 2011-01-25 Advanced Cardiovascular Systems, Inc. Biodegradable polymers for use with implantable medical devices
US7186789B2 (en) 2003-06-11 2007-03-06 Advanced Cardiovascular Systems, Inc. Bioabsorbable, biobeneficial polyester polymers for use in drug eluting stent coatings
US20060135253A1 (en) * 2004-09-10 2006-06-22 Jeffrey George Gaming system and method for providing entry to a contest

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4940954B1 (no) * 1970-02-16 1974-11-06
US3796631A (en) * 1970-11-09 1974-03-12 Choay Sa Processes for preparing polynucleotides
IL37076A (en) * 1971-06-16 1974-05-16 Littauer U A method for stepwise synthesis of oligoribonucleotides of defined sequence using 2'(3')-o-acyl-nucleoside diphosphates and polynucleotide phosphorylase
US4124702A (en) * 1971-07-06 1978-11-07 Merck & Co., Inc. Polynucleotides active as inducers of interferon production in living animal cells
JPS524633B2 (no) * 1972-07-21 1977-02-05
GB1435571A (en) * 1973-04-02 1976-05-12 Searle & Co Polynucleotides
DE2319495C2 (de) * 1973-04-17 1985-01-10 Yeda Research And Development Co., Ltd., Rehovot Verfahren zum selektiven, reversiblen Binden von Biomolekülen an ein Adsorbens in einer chromatographischen Säule
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
FR2252350A1 (en) * 1973-11-22 1975-06-20 Choay Sa Polynucleotide phosphorylase - extraction from E coli, fixation on sepharose, and use in preparing polynucleotides
JPS50107187A (no) * 1974-02-08 1975-08-23
US4006059A (en) * 1974-07-29 1977-02-01 Purdue Research Foundation Hydrophobic noncovalent binding of proteins to support materials
US4000098A (en) * 1974-08-16 1976-12-28 Palo Alto Medical Research Foundation Separation of proteins by hydrophobic adsorption
US4024241A (en) * 1974-09-27 1977-05-17 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
US4075195A (en) * 1976-08-31 1978-02-21 Kraft, Inc. Debittered protein product and method for manufacture
SU619508A1 (ru) * 1976-12-07 1978-08-15 Предприятие П/Я Г-4740 Способ получени полинуклеотидов, обладающих полирибонуклеотидфосфорилазной активностью
JPS5519239A (en) * 1978-07-28 1980-02-09 Green Cross Corp:The Interferon-producing attractant
JPS5618597A (en) * 1979-07-23 1981-02-21 Mitsubishi Chem Ind Ltd Production of oligonucleotide
US4379843A (en) * 1981-01-26 1983-04-12 Peter Cashion Immobilization of polynucleotides and polypeptides with tritylated polysaccharides
US4400375A (en) * 1981-11-23 1983-08-23 Eli Lilly And Company Tobramycin-double stranded RNA complex suitable for inducing interferon
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
US4617376A (en) * 1985-07-01 1986-10-14 Eli Lilly And Company Process for recovering glucagon from pancreas glands
US4820696A (en) * 1985-08-26 1989-04-11 Hem Research, Inc. Modulation of aids virus-related events by double-stranded RNAS
US5063209A (en) * 1985-08-26 1991-11-05 Hem Research, Inc. Modulation of aids virus-related events by double-stranded RNAs
US4945082A (en) * 1985-08-26 1990-07-31 Hem Research, Inc. Controlled dsRNA therapy for human viral infections
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
US4771128A (en) * 1986-10-10 1988-09-13 Cetus Corporation Method of purifying toxin conjugates using hydrophobic interaction chromatography
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
US5091374A (en) * 1987-07-17 1992-02-25 Hem Research Inc. Double-stranded RNA correction of abnormalities in circulating immune complexes and monocyte function
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
AU1820588A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
GB8725606D0 (en) * 1987-11-02 1987-12-09 Soc D Etudes Prod Chimique Preparation polynucleotides
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0350151B1 (en) * 1988-07-07 1994-03-30 Hem Pharmaceuticals Corp. Diagnosing and treating chronic fatigue syndrome
JP2619710B2 (ja) * 1989-02-27 1997-06-11 日本製紙 株式会社 ２′，３′−ジデオキシプリンヌクレオシド類の製造方法

Also Published As

Publication number Publication date
EP0509906A1 (fr) 1992-10-21
SE9201207D0 (sv) 1992-04-15
IE921208A1 (en) 1992-10-21
CH684521A5 (fr) 1994-10-14
BE1004857A3 (fr) 1993-02-09
KR100233393B1 (ko) 1999-12-01
CA2066134A1 (en) 1992-10-17
OA09577A (fr) 1993-01-31
GB9108085D0 (en) 1991-06-05
JPH05262653A (ja) 1993-10-12
DK51192D0 (da) 1992-04-15
GB9207798D0 (en) 1992-05-27
US5736525A (en) 1998-04-07
LU88102A1 (fr) 1992-10-15
AU656574B2 (en) 1995-02-09
GB2255504A (en) 1992-11-11
NO921513D0 (no) 1992-04-15
US5756477A (en) 1998-05-26
FR2675384A1 (fr) 1992-10-23
MY108106A (en) 1996-08-15
SE509801C2 (sv) 1999-03-08
DK51192A (da) 1992-10-17
ZA922699B (en) 1992-12-30
DZ1570A1 (fr) 2002-02-17
SE9201207L (sv) 1992-10-17
FR2675384B1 (fr) 1995-09-15
KR920019363A (ko) 1992-11-19
AU1490992A (en) 1992-10-22
CA2066134C (en) 2002-11-19

Similar Documents

Publication Publication Date Title
MD1224C2 (ro) Utilizare a analogilor nucleozidici cu 1,3-oxatiolan în tratamentul hepatitei B
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
DE59409794D1 (de) Benzoylguanidine, ihre herstellung und ihre verwendung in arzneimitteln
NO20073429L (no) Anvendelse av et antistoff mot interleukin-6-reseptor for fremstilling av et farmasoytisk preparat
EP0509019A4 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
NO951198L (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
ATE28624T1 (de) Zusammensetzungen von polyarylalkanoligomeren sowie verfahren zu deren herstellung.
ATE234615T1 (de) Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren
NO960653L (no) Nytt, farmasöytisk middel for oral administrering omfattende progesteron og en polyetylenglykol sammen med en eksipiens
IS4923A (is) Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara
AU4297089A (en) Dispersable formulation of diclofenac in free acid form
DE69230180D1 (de) Neuartige hefestämme zur herstellung von xylitol
CA2135614A1 (en) Use of urodilatin in pulmonary and bronchial diseases
ITMI911155A1 (it) Perfluoropolieteri ad elevata viscosita' e basso contenuto di ossigeno perossidico, e procedimento per la loro preparazione
FI885454A (fi) Administrationssystem, som laongsamt frigoer substituerade dihydropyridiner.
PT866791E (pt) Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana
NO921513L (no) Komplekser av polyadenylsyre med polyuridylsyre
FI955837A (fi) Menetelmä suun kautta annettavan, kiinteän, diklofenaakkia sisältävän annostelumuodon valmistamiseksi
AU1907992A (en) Pharmaceutical enema preparation
KR890009389A (ko) 바이러스를 억제시키는 방법
AU641279B2 (en) Oligosaccharide derivatives
CA2047802A1 (en) Pharmaceutical compositions
IT1251226B (it) Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
WO1990003172A3 (en) Bile acids for treatment of viral infections
ES2049711T1 (es) Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de la cistinuria.